PARPharmaceuticals
Par Technology Corporation — PE Ratio & Valuation Analysis
₹78.58
-7.53%
Current P/E11.42xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E16.5x30.9% below avg
✅
64.1% Discount to Industry
PAR P/E 11.42x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹10.86 | ₹101 | 9.3x |
| 2024 | ₹11.78 | ₹199 | 16.9x |
| 2023 | ₹9.21 | ₹216 | 23.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Par Technology Corporation Valuation
Par Technology Corporation (PAR) currently trades at 11.42x earnings. The Pharmaceuticals sector average PE is 31.77x. PAR is trading at a discount to peers — may indicate relative value. Historically, PAR has traded at an average PE of 16.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
13.62%
Dividend Yield
0.00%
More on Par Technology Corporation
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.